Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197612 · ClinicalTrials.gov registry record · Phase 3
Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis
A Phase 3 study of Chronic Sinusitis and Polyposis, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT01197612: Completed Phase 3 study of Chronic Sinusitis and Polyposis, sponsored by University of Michigan.
NCT01197612 is a Phase 3 study of Chronic Sinusitis and Polyposis that has completed, run by University of Michigan. The registered enrollment target is 23 participants, below the 193-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01197612, a Phase 3 study of Chronic Sinusitis and Polyposis, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
That high-dose steroid applied to the nasal cavity immediately post-operatively will improve olfaction and healing following endoscopic sinus surgery.
Primary Outcome
will be measured with the University of Pennsylvania Smell Identification Test (UPSIT), whose scores range from 0 to 40, where 0 is the inability to smell anything and 40 is perfect smell identification
Conditions Studied
Interventions
- DRUG pulmicort
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-06 |
| Phase | Phase 3 |
What the finished NCT01197612 record still lists
NCT01197612 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 193-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Chronic Sinusitis appearing as the primary indexed condition, and to 1 intervention - of which pulmicort is the first listed.
NCT01197612 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT01197612 about?
NCT01197612 is a clinical study titled "Nasal Packing as a Drug Delivery System Postoperatively in Chronic Sinusitis With Polyposis". That high-dose steroid applied to the nasal cavity immediately post-operatively will improve olfaction and healing following endoscopic sinus surgery.
What is the current status of trial NCT01197612?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2010-09. Estimated completion is 2012-06.
What conditions does trial NCT01197612 study?
This clinical trial studies the following conditions: Chronic Sinusitis, Polyposis.
What interventions are being tested in trial NCT01197612?
The interventions under investigation include: pulmicort (DRUG).
Who is sponsoring clinical trial NCT01197612?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01197612 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01197612's enrollment target sits among peer trials
23 8th of 9 higher than 2 of 9 other Chronic Sinusitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Factors in Chronic Sinusitis
ACTIVE NOT RECRUITING
-
Randomized Evaluation of Maxillary Antrostomy Versus Ostial Dilation Efficacy Through Long-Term Follow-Up
COMPLETED · NA
-
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
COMPLETED · NA
-
Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
COMPLETED · Phase 2
-
Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery
COMPLETED · NA
-
Safety and Efficacy of Balloon Sinuplasty in Pediatric Sinusitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia